Genaissance and Otsuka collaborate over genetic marker discovery
Under the terms of the agreement, Genaissance will apply its HAP Technology with the goal of identifying the genetic markers. Genaissance and Otsuka will be co-owners of the
Japan-based Ono Pharmaceutical has signed an agreement with US biotechnology company Aitia to collaborate on drug discovery in neurological diseases.